Simparica Trio 6/0.12/25mg

Sarolaner and moxidectin are two potent antiparasitic agents commonly used in veterinary medicine to prevent and treat infestations caused by fleas, ticks, and internal parasites in dogs. Sarolaner belongs to the isoxazoline class of compounds, which acts by targeting the nervous system of parasites, leading to paralysis and death. Moxidectin, on the other hand, is a macrocyclic lactone that disrupts the nervous system of parasites by enhancing the release of gamma-aminobutyric acid (GABA), ultimately causing paralysis and death. Together, these two active ingredients provide broad-spectrum protection against a wide range of parasites, including fleas, ticks, heartworms, and various intestinal worms.

One of the key benefits of sarolaner and moxidectin combination products is their convenience and efficacy in preventing multiple parasitic infestations with just one administration. These products come in various formulations such as chewable tablets, spot-on solutions, or flavored chews, making them easy to administer and well-tolerated by dogs. Additionally, sarolaner and moxidectin offer long-lasting protection, with some formulations providing up to 12 weeks of continuous coverage against fleas and ticks, reducing the need for frequent dosing and ensuring consistent parasite control. Moreover, by preventing parasitic infestations, these products help safeguard the health and well-being of dogs while also protecting against zoonotic diseases that can be transmitted from pets to humans.